BSACI 2021 guideline for the management of egg allergy
Research article published in Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2021)
Abstract
This guideline advises on the management of patients with egg allergy. Most commonly egg allergy presents in infancy, with a prevalence of approximately 2% in children and 0.1% in adults. A clear clinical history will confirm the diagnosis in most cases. Investigation by measuring egg-specific IgE (by skin prick testing or specific IgE assay) is useful in moderate-severe cases or where there is diagnostic uncertainty. Following an acute allergic reaction, egg avoidance advice should be provided. Egg allergy usually resolves, and reintroduction can be achieved at home if reactions have been mild and there is no asthma. Patients with a history of severe reactions or asthma should have reintroduction guided by a specialist. All children with egg allergy should receive the MMR vaccine. Most adults and children with egg allergy can receive the influenza vaccine in primary care, unless they have had anaphylaxis to egg requiring intensive care support. Yellow Fever vaccines should only be considered in egg-allergic patients under the guidance of an allergy specialist. This guideline was prepared by the Standards of Care Committee (SOCC) of the British Society for Allergy and Clinical Immunology (BSACI) and is intended for allergists and others with a special interest in allergy. The recommendations are evidence based. Where evidence was lacking, consensus was reached by the panel of specialists on the committee. The document encompasses epidemiology, risk factors, diagnosis, treatment, prognosis and co-morbid associations.
Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.
Zusammenfassung
This guideline advises on the management of patients with egg allergy.
Warum dies für die Hirudotherapie relevant ist
Diese Leitlinie zur Praxis gibt Empfehlungen zum Management der Eiallergie und behandelt die Diagnose anhand von Anamnese und eispezifischer IgE-Testung, die Meidung von Ei, Wiedereinführungsstrategien sowie Impfempfehlungen einschließlich MMR, Influenza und Gelbfieber. Sie wurde vom Standards of Care Committee der British Society for Allergy and Clinical Immunology für Allergologen und andere Interessierte erstellt. Der Abstract behandelt eine Nahrungsmittelüberempfindlichkeit und erwähnt weder Hirudotherapie noch Blutegeltherapie, Hirudin, das Blutegelsekretom oder verwandte antikoagulatorische Themen. Daher gibt es allein auf Grundlage des Abstracts keine vertretbare Relevanz für das Hirudotherapie-/Blutegelsekretom-Fachgebiet der ASH.
Zitation
BSACI 2021 guideline for the management of egg allergy
Leech SC et al. · Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2021
Verwandter klinischer Kontext
Erfahren Sie, wie diese Forschung mit der klinischen Praxis verknüpft ist
Zur ASH-Bibliothek hinzugefügt: May 27, 2026 · Letzte Aktualisierung der Website: 18. Juni 2026